COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT OF SKIN

REPLICATION STRESS PATHWAY AGENT COMPOSITIONS AND METHODS FOR TREATING CANCER

INHIBITORS OF LINE1 AND USES THEREOF

METHODS OF TFEB ACTIVATION AND LYSOSOMAL BIOGENESIS AND COMPOSITIONS THEREFOR

THERAPEUTIC ANTIBODIES

IL10Ra/IL2Ry SYNTHETIC CYTOKINES

IL2RB/IL2RG SYNTHETIC CYTOKINES

IL10RA binding molecules and methods of use

IL2RG binding molecules and methods of use

Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibody

PD-1 SIGNAL INHIBITOR COMBINATION THERAPY

COMPOSITIONS AND METHODS RELATED TO ANTI-CD19 ANTIBODY DRUG CONJUGATES

Anti-Angiopoietin-2 Antibodies and Uses Thereof

FC-EPSILON CAR

TREATMENTS FOR GASTROINTESTINAL DISORDERS

Compounds, compositions, and methods for the treatment of disease

CONDENSED HETEROCYCLIC DERIVATES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASES

DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS

SALT AND CRYSTAL FORM OF KETOHEXOKINASE INHIBITOR AND USE THEREOF

4-ETHYNYLPYRIDINE DERIVATIVES USEFUL AS GCN2 INHIBITORS

HETEROCYCLIC IMMUNOMODULATOR

System and methods for treating cancer cells with alternating polarity magnetic fields

COLLAGEN COMPOSITIONS AND USES FOR BIOMATERIAL IMPLANTS

RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY

METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES

CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF

Genetically Modified T-Cells and PI3K/AKT Inhibitors For Cancer Treatment

Dosing parameters for CD47 targeting therapies to hematologic malignancies

COMPOSITION FOR USE IN THE TREATMENT OF VIRAL INFECTIONS

INTERFERON-BASED CANCER TREATMENT METHOD AND PHARMACEUTICAL COMPOSITION

LONG-ACTING IL-15 AND USES THEREOF

Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof

A COMPOSITION COMPRISING AN EXTRACT OF ALDER TREE OR THE ISOLATED COMPOUNDS THEREFROM FOR TREATING AND PREVENTING SKELETON MUSCLE-RELATED DISORDER AND THE USE THEREOF

BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA

METHOD OF TREATING CORONOVIRUS INFECTIONS WITH CANNABINOIDS AND DERIVATIVES

LIPOSOMAL FORMULATIONS FOR INHIBITING SARS-CoV-2 REPLICATION AND REDUCING LUNG INFLAMMATION

BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION

Thienopyrrole compounds

GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH HEPATIC IMPAIRMENT

METHODS OF TREATING DIABETIC KIDNEY DISEASE

INTRATHECAL ADMINISTRATION OF LEVETIRACETAM

SALVINORIN COMPOSITIONS

Improved Anti-Hangover Composition, Its Preparation and Uses

TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

REDUCED SEDATION AND DISSOCIATION IN TREATING NEUROLOGICAL DISORDERS

PHARMACEUTICAL COMPOSITIONS COMPRISING INSOLUBLE ACTIVE INGREDIENTS

TREATMENT OF ALZHEIMER'S DISEASE

Tamper resistant dosage forms

TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS

PHARMACEUTICAL COMPOSITION

CD133 RELATED TO ANTICANCER AGENT RESISTANCE IN COLON CANCER AND USE THEREOF

Compositions Useful in Treatment of Spinal Muscular Atrophy

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

PD-1 SIGNAL INHIBITOR COMBINATION THERAPY

LAG-3 ANTAGONIST THERAPY FOR HEPATOCELLULAR CARCINOMA

HIGH AFFINITY ANTIBODIES TARGETING TAU PHOSPHORYLATED AT SERINE 413

COMPOSITIONS HAVING NEUROREGENERATIVE APPLICATIONS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

Stabilized BCL9 peptides for treatment of aberrant Wnt signaling

METHODS OF TREATING CORONAVIRUS

OXADIAZOLE DERIVATIVE

HIGH AFFINITY IL-2 RECEPTOR AGONISTS AND SYNTHETIC NANOCARRIER DOSE SPARING

Compounds and methods for the targeted degradation of bromodomain- containing proteins

SILK-BASED PRODUCT FORMULATIONS AND METHODS OF USE

Oncolytic viruses for modified MHC expression

COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS USING OSCILLOSPIRACEAE MICROBIAL EXTRACELLULAR VESICLES

DEVICE FOR PROCESSING TISSUE

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

ANTI-CANCER ACTIVITY OF PERBORATE SALTS

PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF REMDESIVIR BY INHALATION

APPLICATION OF CANNABIDIOL IN TREATMENT OF CORONAVIRUS INFECTIONS

SYSTEMS, METHODS, AND COMPOSITIONS FOR INFECTIONS

METHODS OF REDUCING INCIDENCE OR RISK OF CEREBRAL FOLATE DEFICIENCY

COMBINATION THERAPY OF PARP INHIBITORS

Compositions and methods for treating centrally mediated nausea and vomiting

COMPANION DIAGNOSTIC FOR AXITINIB

COMPANION DIAGNOSTIC FOR RTK INHIBITORS

ORAL FORMULATIONS AND USES THEREOF

ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE

METHODS OF TREATING SOLID TUMORS USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY

COMPOSITIONS AND METHODS FOR TREATING PAIN AND/OR INFLAMMATION

THERAPY OF POST-OPERATIVE NAUSEA AND VOMITING

COMPOSITIONS OF EDTA HAVING ACTIVITY AGAINST PLANKTONIC AND BIOFILM CELLS OF CLINICALLY RELEVANT PATHOGENS

USE OF CANNABINOIDS IN THE TREATMENT OF ANGELMAN SYNDROME

INTRANASAL ADMINISTRATION OF AN ANTIOXIDANT COMPOUND FOR TREATING CORONAVIRUS INFECTION

Intravaginal Ring Device for the Delivery of Aromatase Inhibitor

BREAST CANCER BIOMARKERS AND METHODS OF USE

Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon

PRODUCTS AND COMPOSITIONS

USE OF P38 INHIBITORS TO REDUCE EXPRESSION OF DUX4

UVEAL MELANOMA TREATMENT USING SEA-CD40

METHODS OF TREATMENT USING CHLOROTOXIN CONJUGATES

COMPOUNDS AND METHODS OF PROMOTING OLIGODENDROCYTE PRECURSOR DIFFERENTIATION

ONCOLYTIC VIRUS VACCINE AND DRUG FOR TREATING TUMORS BY COMBINING ONCOLYTIC VIRUS VACCINE WITH IMMUNE CELLS

AMHR2-ED CANCER VACCINE FORMULATIONS

IMMUNITY ENHANCING AGENT FOR CANCER BY ALLERGIN-1 ANTAGONIST

METHODS AND COMPOSITIONS FOR IMMUNOMODULATION

MODIFIED KISSPEPTIN RECEPTOR AGONISTS FOR FATTY LIVER DISEASE

MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL RESPIRATORY DISEASES

VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION

Immunomodulatory compositions comprising microbial entities

DERIVED MULTIPLE ALLOGENEIC PROTEINS PARACRINE SIGNALING (d-MAPPS) REGENERATIVE BIOLOGICS PLATFORM TECHNOLOGY ADJUVANT THERAPY FOR THE PREVENTION AND TARGETED TREATMENT OF CANCER AND OTHER DISORDERS

COMPOSITIONS FOR PREVENTING OR TREATING DIABETIC SKIN DISEASE COMPRISING EXOSOME-DERIVED FROM THROMBIN-TREATED STEM CELL

TREATMENT OF MYOPIC PROGRESSION

Nucleic acid oligomers and uses therefor

Ketogenic Diet and Ketone Supplementation for Cancer Therapy

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

GLYCAN COMPOSITIONS AND USES THEREOF

METHODS FOR TREATING GLIOBLASTOMA

Treatment of cancer with a RAF inhibitor

Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates

USE OF THYROMIMETICS FOR THE TREATMENT OF CANCER

METHODS OF TREATMENT FOR GASTROINTESTINAL MOTILITY DISORDERS

Methods for treating chronic obstructive pulmonary disease

USE OF JUMONJI C DEMETHYLASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF CHEMOTHERAPY RESISTANCE AND RADIORESISTANCE IN CANCER

3-(Hydroxy)-Pyridin-4(1H)-One Compounds and Methods of Making and Using the Same

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING 3-KETOACYL CoA THIOLASE INHIBITOR AND CARNITINE ACYLCARNITINE CARRIER INHIBITOR

INHALABLE RAPAMYCIN FORMULATION FOR THE TREATMENT OF PULMONARY HYPERTENSION

CRF1 RECEPTOR ANTAGONIST FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS

OXYMETAZOLINE FOR THE TREATMENT OF ANO-RECTAL DISORDERS

PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF TISSUE INJURY

METHOD OF INCREASING THE POPULATION OF COPROCOCCUS SPP. IN THE GUT MICROBIOME

COMPOSITIONS OF BIOACTIVE FULVATE FRACTIONS AND USES THEREOF

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING NAPHTHOQUINONE-BASED COMPOUND AND IMMUNE CHECKPOINT INHIBITOR AS ACTIVE INGREDIENTS

METHOD FOR PREPARATION OF LIPOSOMES

IMMOBILIZED ENZYME-BASED WOUND DEBRIDEMENT

OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF

ISOTHERMAL REAL-TIME PCR METHOD FOR DETERMINING PRESENCE OF A PRE-DETERMINED NUCLEIC ACID SEQUENCE IN HUMAN SAMPLES

METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES

PH20 polypeptide variants, formulations and uses thereof

NOVEL HYALURONIDASE VARIANTS WITH IMPROVED STABILITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

TREATMENT OF METASTATIC BREAST CANCER

Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Lenalidomide and Dexamethasone

MULTIMERS FOR VIRAL STRAIN EVOLUTION

Therapeutic variant alpha-2-macroglobulin compositions

GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS

Pyrrolopyrimidines as CFTR Potentiators

KDM1A inhibitors for the treatment of disease

MAP4K3 SMALL MOLECULE DRUG INHIBITORS AND METHODS OF USE THEREOF

PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF

4-ethynylpyridine derivatives useful as GCN2 inhibitors

Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide

CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS

Chlorinated tetralin compounds and pharmaceutical compositions

Substituted Heterocyclyl Derivatives as CDK Inhibitors

HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS

CONTRAST AGENTS FOR DETECTION OF ENZYME ACTIVITIES BASED ON MELANIN SYNTHESIS

Bisphosphonate-Modified Liposomes Containing Nanoparticles

METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES

TOPICAL SKIN CARE COMPOSITION

USE OF MULBERRY EXTRACT FOR CONTROLLING POSTPRANDIAL GLUCOSE RESPONSE

Therapeutic bacteriophage compositions for treating infection

BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS

PRODUCTS AND METHODS USING A PLATELET-DERIVED HEMOSTATIC AGENT FOR CONTROLLING BLEEDING AND IMPROVING HEALING

METHODS OF TREATING OXIDATIVE STRESS TO MODULATE REDOX BALANCE, PREVENTING OXIDATIVE STRESS INDUCED CELL DAMAGE AND DEATH

THERAPEUTIC COMPOSITION FOR ARRESTING, PREVENTING AND REVERSING DENTAL DISEASE

METHODS OF TREATING UPPER GASTROINTESTINAL DISORDERS IN PPI REFRACTORY GERD

Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking

CANNABINOID AND OMEGA FATTY ACID COMPOSITIONS AND METHODS OF USING

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

Replication stress pathway agent compositions and methods for treating cancer

METHODS AND COMPOSITIONS FOR TREATING RNA VIRAL INFECTIONS

Dosage Regimen for the Treatment of Cancer

Methods for Treating Systemic Lupus Erythematosus

Cannabinoid formulation: production method and use

Treating benign prostatic hyperplasia

COMPOSITIONS AND METHODS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) AND INFLAMMATORY DISORDERS CAUSED BY CORONAVIRUSES AND OTHER RESPIRATORY PATHOGENS OR AGENTS THAT MEDIATE PULMONARY INJURY, INFLAMMATION OR ACUTE RESPIRATORY DISTRESS, AND RELATED COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HUMAN SARS CORONAVIRUS INFECTION, COVID-19 DISEASE AND RELATED SYMPTOMS

METHODS OF TREATING SQUAMOUS CELL CARCINOMAS WITH FARNESYLTRANSFERASE INHIBITORS

Intravenous baclofen formulations and treatment methods

COMPOSITIONS COMPRISING GARDOS CHANNEL ANTAGONISTS AND THEIR USES

Dosage regime with esketamine for treating major depressive disorder

Use of cannabinoids in the treatment of epilepsy

METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER

EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE

METHODS FOR THE TREATMENT OF PRESBYOPIA

TOPICAL MONTELUKAST FOR TREATMENT OF ATOPIC DERMATITIS

INTERFERON- INDUCING OLIGONUCLEOTIDE DUPLEXES AND METHODS OF USE

METHODS FOR ENHANCING NATURAL KILLER CELL PROLIFERATION AND ACTIVITY

EXPANSION OF GAMMA DELTA T CELLS, COMPOSITIONS, AND METHODS OF USE THEREOF

A BISPECIFIC ANTI-PD-L1/VEGF ANTIBODY AND USES THEREOF

TREATMENT OF METASTATIC PANCREATIC ADENOCARCINOMA

ANTI-SIRPg Compounds

Treating refractory migraine

BROADLY NEUTRALIZING AND POTENT ANTIBODIES AGAINST HIV

METHOD FOR THE TREATMENT OF A RELAPSING-REMITTING CONDITION

PROCESS FOR THE PREPARATION OF TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS FOR USING THE SAME FOR THE TREATMENT OF CANCER

QUINAZOLINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF

PanK Modulators and Methods Using Same

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

SUBSTITUTED FUSED HETEROAROMATIC BICYCLIC COMPOUNDS AS KINASE INHIBITORS AND THE USE THEREOF

PROCESS, COMPOSITIONS, AND CRYSTALLINE FORMS OF SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS

HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER

METHODS AND COMPOSITIONS FOR CANCER TREATMENT

Protein antigens and uses thereof

ENHANCING IMMUNE RESPONSES THROUGH TARGETED ANTIGEN EXPRESSION

HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY

VACCINE COMPOSITIONS COMPRISING C-C MOTIF CHEMOKINE 22 (CCL22) OR FRAGMENTS THEREOF

Compositions and Methods for Treating Granulomatosis with Polyangiitis

PREVENTING AND TREATING VIRAL INFECTIONS

Composition comprising an algal proteoglycan extract and use thereof

IONIC SELF-ASSEMBLING PEPTIDES

Compositions and Uses Thereof

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF DIAPER RASH, ATHLETE?S FOOT, CONTACT DERMATITIS, PERSPIRATION, AND BODY ODOR

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF PULMONARY HYPERTENSION

ISOTONIC LIPID EMULSION

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

METHODS OF USE OF ALLERGEN-SPECIFIC T CELLS IN ALLERGY AND ASTHMA

FORMULATIONS OF CALCIUM AND PHOSPHATE FOR ORAL INFLAMMATION

LOZENGE

TARGETING ADISPSIN FOR NONALCOHOLIC STEATOHEPATITIS (NASH)- INDUCED LIVER FIBROSIS

FORMULATION COMPRISING CANNABINOIDS

Method for Treating Melanoma

POLYMORPHS OF ARRY-380, A SELECTIVE HER2 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIBITOR COMPOUNDS TO TREAT RB-POSITIVE TUMORS

METHOD OF INHIBITING MUTANT C-KIT

TREATMENT FOR PSORIASIS AND SKIN INFLAMMATORY DISEASES

Compositions and methods for treatment of edema

LURBINECTEDIN IN THE TREATMENT OF MALIGNANT MESOTHELIOMA

MICROTUBULE POLYMERIZATION INHIBITOR PRODRUGS AND METHODS OF USING THE SAME

Pharmaceutical combinations for treating cancer

Antiviral use of FABP4 modulating compounds

AMINO ACID DERIVATIVES CONTAINING A DISULFANYL GROUP AS AN INHIBITOR OF NEP AND APN FOR THE PREVENTION AND TREATMENT OF TRIGEMINAL NERVE PAIN

Hepatitis B antiviral agents

METHODS OF TREATING SUICIDALITY

METHOD OF TREATING CANCER

LIPOSOMAL OZONE NANOSOLUTIONS

INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS

DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS

DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS

Treatments for benign prostatic hyperplasia

Compositions and methods for treating canker sores

Method and system for distraction neurogenesis

METHOD FOR IMPROVING BEHAVIORAL DEFICITS OF SUBJECT AT RISK FOR OR IN EARLY STAGE OF ALZHEIMER DISEASE OR OTHER NEURODEGENERATIVE DISEASES

METHOD OF DIAGNOSIS OF INFECTION BY THE SARS-COV-2 VIRUS

TREATMENT OF NEUROLOGICAL DISEASES USING MODULATORS OF GENE TRANSCRIPTS

Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis

TREATMENT OF ATOPIC DERMATITIS

ANTIGEN-BINDING PROTEINS THAT ANTAGONIZE LEPTIN RECEPTOR

Binding Members to PD-L1

MONOCLONAL ANTIBODIES AGAINST LILRB1 FOR DIAGNOSTIC AND THERAPEUTIC USE

ANTI-CLAUDIN18.2 ANTIBODY AND USE THEREOF

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

ACVR1 (ALK2) RECEPTOR INHIBITION TO TREAT NEUROLOGICAL DISEASES

Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same

Compositions and methods for the removal of biofilms

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

HUMANIZED ACE2-FC FUSION PROTEIN FOR TREATMENT AND PREVENTION OF SARS-COV-2 INFECTION

Polypeptides Comprising Modified IL-2 Polypeptides and Uses Thereof

Twisted gastrulation polypeptides and uses thereof

CDK inhibitors and their use as pharmaceuticals

Selective estrogen receptor degraders

BICYCLIC UREA KINASE INHIBITORS AND USES THEREOF

METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS

IRAK DEGRADERS AND USES THEREOF

MORPHOLINYLPYRIDONE COMPOUNDS

TREX1 INHIBITORS AND USES THEREOF

KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE

Next Generation FKBP52 Targeting Drugs for the Treatment of Prostate and Breast Cancer

YAP1 inhibitors that target the interaction of YAP1 with OCT4

TRIANTENNARY N-ACETYLGALACTOSAMINE MODIFIED HYDROXYL POLYAMIDOAMINE DENDRIMERS AND METHODS OF USE THEREOF

ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER

VACCINATION IN NEWBORNS AND INFANTS

Indoleamine 2,3-dioxygenase based immunotherapy

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

USE OF AN INHIBITOR OF ACTIN REMODELING MODULATOR FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OF SLEEP DEPRIVATION-INDUCED MEMORY DEFICIT

ORAL GEL COMPOSITIONS

Genetically Modified Bovine Herpesvirus Type 1 (BHV-1) for use to Treat Cancer

ANTI-TUMOR COMPOSITION

PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

Marine Bacterial Exopolysaccharide Derivatives and Uses Thereof in the Treatment of Mucopolysaccharidoses

USE OF STAT4 INHIBITORS FOR PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE

USE OF PHYTOCANNABINOIDS FOR TREATING MULTIPLE MYELOMA

ANTI-CANCER EFFECTS OF JAK2 INHIBITORS IN COMBINATION WITH THALIDOMIDE DERIVATIVES AND GLUCOCORTICOIDS

TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF

TARGETING DNA-PKCS AND B7-H1 TO TREAT CANCER

Use of PPAR-delta agonists in the treatment of disease

COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING EGFR OR HER2 EXON 20 MUTATIONS

COMPOSITIONS AND METHODS FOR TREATMENT

TREATMENT FOR THE INFLAMMATORY BOWEL DISEASE

Methods of using 4(1)-quinolone derivatives

TREATMENT OF ATRIAL DYSFUNCTION

SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE

COMPOSITIONS, METHODS OF TREATING AND PREVENTING FUNGAL INFECTIONS, AND METHODS OF INHIBITING PRP8 INTEIN EXPRESSION

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

COMBINATION THERAPIES

CATECHIN CONTAINING COMPOSITIONS AND USES

Extended Duration Local Anesthetic Formulation

Compositions and methods for treating pulmonary disorders

COMPOSITIONS AND METHODS FOR THE TREATMENT OF COVID-19